These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 21568945)

  • 1. A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy.
    Palm M; Basu S; Larsson A; Wernroth L; Åkerud H; Axelsson O
    Acta Obstet Gynecol Scand; 2011 Nov; 90(11):1244-51. PubMed ID: 21568945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twin pregnancy and the risk of preeclampsia: bigger placenta or relative ischemia?
    Bdolah Y; Lam C; Rajakumar A; Shivalingappa V; Mutter W; Sachs BP; Lim KH; Bdolah-Abram T; Epstein FH; Karumanchi SA
    Am J Obstet Gynecol; 2008 Apr; 198(4):428.e1-6. PubMed ID: 18191808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
    Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N; Naicker T; Rajakumar A; Moodley J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental Angiogenic Factors Are Associated With Maternal Thyroid Function and Modify hCG-Mediated FT4 Stimulation.
    Korevaar TI; Steegers EA; de Rijke YB; Visser WE; Jaddoe VW; Visser TJ; Medici M; Peeters RP
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1328-34. PubMed ID: 26204137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia.
    Rana S; Powe CE; Salahuddin S; Verlohren S; Perschel FH; Levine RJ; Lim KH; Wenger JB; Thadhani R; Karumanchi SA
    Circulation; 2012 Feb; 125(7):911-9. PubMed ID: 22261192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study.
    Korevaar TI; Steegers EA; Schalekamp-Timmermans S; Ligthart S; de Rijke YB; Visser WE; Visser W; de Muinck Keizer-Schrama SM; Hofman A; Hooijkaas H; Bongers-Schokking JJ; Russcher H; Tiemeier H; Jaddoe VW; Visser TJ; Medici M; Peeters RP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1627-34. PubMed ID: 24885632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes.
    Salahuddin S; Wenger JB; Zhang D; Thadhani R; Karumanchi SA; Rana S
    Hypertens Pregnancy; 2016 Aug; 35(3):330-45. PubMed ID: 27028795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
    Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
    Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A longitudinal study of circulating angiogenic and antiangiogenic factors and AT1-AA levels in preeclampsia.
    Sahay AS; Patil VV; Sundrani DP; Joshi AA; Wagh GN; Gupte SA; Joshi SR
    Hypertens Res; 2014 Aug; 37(8):753-8. PubMed ID: 24718301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predictive value of the sFlt1/PlGF ratio for the diagnosis of preeclampsia in high-risk patients].
    Husse S; Gottschlich A; Schrey S; Stepan H; Hoffmann J
    Z Geburtshilfe Neonatol; 2014 Feb; 218(1):34-41. PubMed ID: 24595913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Moore Simas TA
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of angiogenic factors and their association with preeclampsia among pregnant women at Mulago National Referral Hospital in Uganda.
    Nabweyambo S; Sande OJ; McGovern N; Bwanga F; Ssekagiri A; Keesiga A; Adroma M; Wasswa R; Atuheirwe M; Namugenyi J; Castelnuovo B; Nakimuli A
    PLoS One; 2021; 16(5):e0251227. PubMed ID: 34010327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction.
    Kodama Y; Kitta Y; Nakamura T; Takano H; Umetani K; Fujioka D; Saito Y; Kawabata K; Obata JE; Mende A; Kobayashi T; Kugiyama K
    J Am Coll Cardiol; 2006 Jul; 48(1):43-50. PubMed ID: 16814647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia.
    March MI; Geahchan C; Wenger J; Raghuraman N; Berg A; Haddow H; Mckeon BA; Narcisse R; David JL; Scott J; Thadhani R; Karumanchi SA; Rana S
    PLoS One; 2015; 10(5):e0126815. PubMed ID: 25965397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia.
    Staff AC; Braekke K; Harsem NK; Lyberg T; Holthe MR
    Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):33-9. PubMed ID: 15935542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.